http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#Head http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#assertion http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#provenance http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#pubinfo http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#assertion http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_1 http://www.selventa.com/vocabulary/variantOf http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=1771 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/ontology-lookup/?termId=MOD:00000 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/ontology-lookup/?termId=MOD:00696 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://disease-ontology.org/term/DOID:1324 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://purl.obolibrary.org/obo/CLO_0007986 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_1 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/increases http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://www.ebi.ac.uk/chebi/searchId.do?chebiId=3722 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#assertion http://www.w3.org/2000/01/rdf-schema#label a(CHEBI:cisplatin) -> p(HGNC:CDK2,pmod(P,Y,15)) http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#provenance http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_4 http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/version 20131211 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_3 http://www.w3.org/ns/prov#value As shown in Figure 2A, in the absence of doxycycline, both Tyr15-phosphorylated cdk2 and cdk1 accumulate in response to cisplatin treatment. After depletion of cdk2, Tyr15 phosphorylation of cdk1 increased to the same degree as in cells in which cdk2 levels were intact (Figure 2A, left-hand panel). However, in the absence of cdk1, phosphorylation of cdk2 at Tyr15 was compromised, indicating cdk2 activity was not reduced after DNA damage treatment (Figure 2A, righthand panel). http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_3 http://www.w3.org/ns/prov#wasQuotedFrom http://www.ncbi.nlm.nih.gov/pubmed/19683496 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_4 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.ncbi.nlm.nih.gov/pubmed/19683496 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#_3 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU#pubinfo http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU http://purl.org/dc/terms/created 2014-07-03T14:33:36.101+02:00 http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RADlnX2GvIXLFaWvQFuk0kNXz9VgeItVsdGT2tMD9_KUU http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234